Daily intake of aspirin decreases risk of ovarian cancer: study
A new study shows that daily use of aspirin can reduce the risk of ovarian cancer in people at high risk.
Another 2018 study also showed that daily intake of aspirin can decrease ovarian cancer rates. However, this study is the first to examine the advantages of non-prescription drugs for high-risk individuals.
Ovary cancer is the most deadly gynecological cancer. Most of the known risk factors for ovarian cancer—such as family history, BRCA 1 and 2 mutations, and endometriosis—cannot be altered”, According to Britton Tabert, Ph.D., MS, Professor of Obstetrics and Gynaecology at the University of Utah School of Medicine, in a university news release.
To conduct the study, the researchers clustered data from 17 studies covering over 8,300 cases of ovarian cancer to analyze published data.
Because aspirin was helpful for people with two or more risk factors, we hope that patients and clinicians will be able to use this research to have an informed conversation about potential prevention measures,” said Tabert. “Individuals should consult with their health care providers before starting new medications to find the best balance between potential risks and potential benefits.”
Trabert received an award related to her work on aspirin use and lower ovarian cancer rates.
The study was published in the Clinical Oncology journal.